Dash Bio raised $30 million in Series A funding.
- Amount
- $30M
- Stage
- Series A
- Announced
- 3 August 2026
- Lead
- Oak HC/FT
- Other investors
- Freestyle Capital, Swift Ventures
- Use of funds
- Scale commercial operations, expand assay menu and laboratory capacity, and develop software platform.
- Total raised
- $47.5M to date
- Checked
- Amount and date checked against the press source